老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Summit Therapeutics PLC

15.71
-1.4250-8.32%
成交量：502.28万
成交额：7,991.14万
市值：125.29亿
市盈率：-14.05
高：16.79
开：16.76
低：15.58
收：17.13
52周最高：29.23
52周最低：12.07
股本：7.98亿
流通股本：1.54亿
量比：0.90
换手率：3.25%
股息：- -
股息率：- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
净资产收益率：-192.50%
总资产收益率：-101.61%
市净率：19.89
市盈率(LYR):-10.88

数据加载中...

总览公司新闻资讯公告
2020/09/28

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/28

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/09/18

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/06/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/26

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超过5%披露

General statement of acquisition of beneficial ownership
2020/01/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露报告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
更多